Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models

SIMPLE SUMMARY: As a preclinical model for personalized cancer therapy, the patient-derived xenograft (PDX) model is suitable because it provides the best representation of the original tumor, but it still has many limitations. We analyzed gynecologic cancer PDX models with their clinical informatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Ha-Yeon, Lee, Eun-ju, Yang, Wookyeom, Kim, Hyo Sun, Chung, Dawn, Cho, Hanbyoul, Kim, Jae-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834149/
https://www.ncbi.nlm.nih.gov/pubmed/35159096
http://dx.doi.org/10.3390/cancers14030829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834149/
https://www.ncbi.nlm.nih.gov/pubmed/35159096
http://dx.doi.org/10.3390/cancers14030829

Ejemplares similares